Shareholding disclosure

Anna Loraschi

Declared position

Threshold

Fell below threshold

Timeline

Published

06.08.2022

Transaction

01.08.2022

Transfer date

01.08.2022

Voting rights breakdown

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAM8400014

Beneficial owner

Anna Loraschi

Declared address

Anna Loraschi, milan

on a consolidated basis, as Anna Loraschi is the controlling shareholder of Wealthpro LTD

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Anna Loraschi

IGEA Pharma N.V.06.08.2022TAM8400014

Disclosure summary

Anna Loraschi disclosed a holding in IGEA Pharma N.V. that fell below the publication threshold, published by SIX Exchange Regulation on 06.08.2022, at 3% of voting rights. Notice category: Single shareholder.

Disclosed position

Below threshold

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Anna Loraschi disclosed a holding in IGEA Pharma N.V., published on 06.08.2022.

Publication date06.08.2022

Transaction date01.08.2022

Transfer date01.08.2022

Issuing companyIGEA Pharma N.V.

Beneficial ownerAnna Loraschi

Declared addressAnna Loraschi, milan

CategorySingle shareholder

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

ExchangeXSWX

Notification IDTAM8400014

Conditions

on a consolidated basis, as Anna Loraschi is the controlling shareholder of Wealthpro LTD

Source: SIX Exchange Regulation · Publication date: 06.08.2022

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open